About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Liver Surgery and Transplantation
›
top-articles
Department of Liver Surgery and Transplantation
214
(top 1%)
papers
6.1K
(top 1%)
citations
40
(top 1%)
h
-index
71
(top 1%)
g
-index
259
all documents
8.1K
doc citations
1.4K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Cell
2019
629
2
Targeted therapy for hepatocellular carcinoma
Signal Transduction and Targeted Therapy
2020
320
3
Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level
Cancer Discovery
2022
286
4
Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation
Cancer Cell
2021
253
5
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
Cancer Cell
2019
213
6
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
Cancer Cell
2019
182
7
Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
Gut
2019
180
8
FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells
Nature
2018
174
9
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
Liver Cancer
2020
172
10
Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis
Hepatology
2020
170
11
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
Molecular Cancer
2020
147
12
A Positive Feedback Loop Between Cancer Stem‐Like Cells and Tumor‐Associated Neutrophils Controls Hepatocellular Carcinoma Progression
Hepatology
2019
140
13
International consensus statement on robotic hepatectomy surgery in 2018
World Journal of Gastroenterology
2019
134
14
MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
Gastroenterology
2019
131
15
Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma
Journal of Hepatology
2020
124
16
Consensus Guidelines for the Use of Fluorescence Imaging in Hepatobiliary Surgery
Annals of Surgery
2021
121
17
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
Cancer Cell
2022
120
18
Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients
BMC Cancer
2018
113
19
Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma
Clinical Cancer Research
2019
109
20
Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing
Cell Research
2018
106
21
Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma
OncoImmunology
2019
96
22
Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning
Gut
2021
93
23
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma
Annals of Surgery
2020
88
24
Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression
Cell Discovery
2020
84
25
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
Nature Metabolism
2023
77
26
Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for
RAS
Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial
Journal of Clinical Oncology
2020
76
27
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases
Hepatology International
2020
68
28
Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
Journal of Hematology and Oncology
2021
68
29
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
Cell Death and Disease
2020
65
30
Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma
Journal of Hepatology
2018
63
31
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma
Journal of Hepatology
2022
62
32
Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine
Journal of Integrative Medicine
2018
61
33
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors
Theranostics
2019
61
34
CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma
Cancer Research
2022
57
35
Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis
Cell Death and Disease
2021
56
36
Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3
Cell Death and Disease
2021
55
37
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)
Hepatobiliary Surgery and Nutrition
2022
55
38
LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway
Journal of Cancer
2020
53
39
Spatial omics: Navigating to the golden era of cancer research
Clinical and Translational Medicine
2022
53
40
PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma
Journal of Hepatology
2022
52
41
Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma
Carcinogenesis
2020
51
42
Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection
Cancer Immunology, Immunotherapy
2019
50
43
Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence
Journal of Hepatology
2019
49
44
Propensity Score–Matched Analysis Comparing Robotic and Laparoscopic Right and Extended Right Hepatectomy
JAMA Surgery
2022
46
45
Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinoma
Theranostics
2018
45
46
Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics
Hepatology
2022
43
47
International multicentre propensity score-matched analysis comparing robotic
versus
laparoscopic right posterior sectionectomy
British Journal of Surgery
2021
42
48
Splicing Regulator p54nrb/Non–POU Domain–Containing Octamer‐Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box–Dependent Interacting Protein 1 in Hepatocellular Carcinoma
Hepatology
2020
40
49
Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma
Nature Communications
2022
40
50
Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
Liver Cancer
2021
39
site/software ©
exaly
; All materials licenced under
CC by-SA
.